The abstract is read at the publisher; the summary is JClub's.
Engineered human IL-39 heterodimers, disulfide-linked from IL-23α and EBI3, are secreted and activate IL-23R and gp130 on primary human immune cells.
- Why it matters: Human IL-39’s existence and function have been controversial, and understanding its biogenesis and signaling is needed to map protective versus pathological immunity.
- What they did: The study combined computer modeling with experiments in human cells to identify destabilizing structural features, then engineered IL-23α and EBI3 to form secreted disulfide-linked heterodimers.
- The result: The engineered cytokine triggered STAT1 and STAT3 phosphorylation and drove proinflammatory cytokine secretion in primary human immune cells, overcoming limits in human IL-39 formation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.